Looks like the analyst have revised the earnings per share for 2015 from 4c plus to 3.1c. Not sure how they arrived at that from the annual report. I have read about concerns with the development pipeline transparency.
"MPl revenue expected to be down in FY15 as a result of reduced branded US Doryx™ sales reflecting the recent lower underlying prescription volumes and anticipated resultant destocking at Actavis and lower licensing fee income"
Doryx was a big earner for them before they bought Metrics .
Based on current earnings the PE is 24. That is pretty strong. CSL is 25.32 which is a superior company. Not sure MYX is going to retrace based on fundamentals.
Any thoughts???
Earnings Downgrade
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.30 |
Change
0.000(0.00%) |
Mkt cap ! $365.8M | |||
| Open | High | Low | Value | Volume |
| $4.30 | $4.39 | $4.23 | $1.190M | 275.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1673 | $4.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.31 | 598 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |